Clark Eliana 4
4 · Intellia Therapeutics, Inc. · Filed Jun 22, 2023
Insider Transaction Report
Form 4
Clark Eliana
EVP, Chief Technical Officer
Transactions
- Sale
Common Stock
2023-06-20$45.00/sh−5,000$225,000→ 45,146 total - Exercise/Conversion
Common Stock
2023-06-20$12.27/sh+5,000$61,350→ 50,146 total - Exercise/Conversion
Stock Option (right to buy)
2023-06-20−5,000→ 57,750 totalExercise: $12.27Exp: 2030-02-02→ Common Stock (5,000 underlying)
Footnotes (2)
- [F1]The reported sale of 5,000 shares on this Form 4 occurred automatically pursuant to a 10b5-1 trading plan adopted by the reporting person on March 21, 2023.
- [F2]The stock option award was issued pursuant to the Intellia Therapeutics, Inc. Amended and Restated 2015 Stock Option and Incentive Plan and had vested as to 64,062 shares as of June 20, 2023.